Implanting a drug-eluting intrauterine device in the womb delayed the progression of cancer in some women with early-stage endometrial cancer and enabled nine out of 39 participants to conceive before undergoing total hysterectomy, researchers found. They said they hope to test the device, which inhibits cancer progression by delivering progesteronelike hormones to the patients' womb lining, in larger clinical trials.

Full Story:

Related Summaries